Sign in Subscribe
Cystic fibrosis

Cystic Fibrosis Research Reveals New Insights into Immune Response

Strategic Insights

— 1 min read

Researchers at the Medical University of Innsbruck have made a groundbreaking discovery in the field of cystic fibrosis, providing new insights into the immune response of patients with mild lung disease. According to a recent study published in the International Journal of Molecular Sciences, the measurement of cytokines in induced sputum and nasal lavage samples has been performed for years in people with cystic fibrosis. The research aimed to directly compare sputum and nasal lavage samples and interpret results based on disease severity in patients who were categorized as having mild or severe lung disease.

Key Takeaways:

  • The study involved 32 sample pairs from 29 patients, with 13 patients classified as having mild lung disease and 19 patients classified as having severe lung disease.
  • In the patients classified as severe, many systemic inflammatory markers and sputum cytokines were significantly higher compared to those in the mild patients.
  • However, all the markers measured in the nasal lavage (NL) were higher in the mild patients, indicating a possible site-specific immune response.
  • The research suggests that inflammation must be interpreted individually depending on the compartment in which it is measured, and further research is needed to accurately understand inflammatory markers measured in NL.
  • The study highlights the importance of considering site-specific immune responses in patients with cystic fibrosis, particularly in those with mild lung disease.

Statistics:

  • 29 patients were involved in the study, with 13 classified as having mild lung disease and 19 classified as having severe lung disease.
  • 32 sample pairs were included in the study, with each pair consisting of a sputum and a nasal lavage sample.
  • 6 cytokines (IL-1b, 2, 6, 8, 10, and 17a) were measured in each sputum and nasal lavage sample.
  • The serum inflammatory markers neutrophil elastase (NE), IL-1b, 2, 6, 8, 10, and 17a were measured in each sputum and nasal lavage sample.
  • The results showed a significant difference in cytokine levels between mild and severe lung disease patients, with higher levels in severe patients.

Sources:

  • Cytokines Measured in Nasal Lavage Compared to Induced Sputum in Patients with Mild Cystic Fibrosis. International Journal of Molecular Sciences, 2024,25(20). (International Journal of Molecular Sciences - http://www.mdpi.com/journal/ijms)
  • NewsRx. Medical University of Innsbruck Researcher Updates Knowledge of Cystic Fibrosis (Cytokines Measured in Nasal Lavage Compared to Induced Sputum in Patients with Mild Cystic Fibrosis). Respiratory Therapeutics Week. October 28, 2024; p 3097.

Read more